PVLA
Palvella Therapeutics, Inc
138.20$
-5.4%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 99.5% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 99.0% | 99.8% | 99.8% | |
| 55.4% | 45.0% | 97.7% | 78.8% | 94.4% | 94.8% | 95.2% | 95.5% | 95.0% | 97.4% | 78.3% | 74.1% | |
| 75.5% | 68.2% | 97.7% | 78.8% | 94.4% | 94.8% | 95.2% | 95.5% | 95.0% | 97.4% | 99.3% | 98.8% | |
| 1.8% | 15.6% | 113.3% | 18.6% | 4.3% | 2.6% | 2.5% | 2.7% | 3.3% | 0.0% | – | – | |
| 48.6% | 30.8% | 198.1% | 25.3% | 20.7% | 29.0% | 30.0% | 35.2% | 42.2% | 53.0% | 11.9% | 14.4% | |
| 48.6% | 30.8% | 42.7% | 25.3% | 20.7% | 13.6% | 11.3% | 13.0% | 15.4% | 19.0% | 3.5% | 4.7% | |
| 20.7% | – | – | – | – | – | – | – | – | 0.3% | 0.1% | 0.1% | |
| 4.7% | 8.7% | 16.0% | 3.9% | 3.9% | 5.2% | 5.6% | 6.2% | 5.2% | 7.7% | 2.1% | 2.7% | |
| 51.4% | 69.2% | -98.1% | 74.7% | 79.3% | 71.0% | 70.0% | 64.8% | 57.8% | 47.0% | 88.1% | 85.5% | |
| -522.7% | -814.3% | -1,233.4% | -1,291.2% | -1,590.2% | -106.2% | -128.3% | -151.0% | -183.4% | -227.4% | -57.3% | -68.3% | |
| 2.1% | 3.2% | 19.8% | 5.2% | 6.4% | 2.5% | 2.8% | 15.0% | 16.5% | 18.9% | 5.0% | 5.7% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.